Clin2
NCT07382271Possibly a fitNot yet recruiting

Phage therapy for drug-resistant UTIs

Urinary Tract InfectionsUrinary Tract Infections Caused by Drug-resistant Bacteria

Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tests whether specially targeted viruses (phages) can treat urinary tract infections caused by bacteria that don't respond to standard antibiotics. If you have a stubborn UTI that hasn't gotten better with antibiotics, this approach may offer a new option.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
6 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have a urinary tract infection caused by drug-resistant bacteria.
  • Your infection bacteria are resistant to key antibiotics, or antibiotics haven't worked for at least 7 days, or you can't take the needed antibiotics due to side effects or allergies.
  • A specific virus that can kill your bacteria has been found and is available for your treatment.
  • You are able to have a urinary catheter or tube placed to deliver the treatment directly into your bladder or kidney.
  • You and your family have read and signed a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07559318Recruiting
Optimizing Antibiotic Choice for Urinary Tract Infections

This study helps doctors choose the best antibiotic for urinary tract infections (UTIs) by looking at urine culture results. You'll be treated as an outpatient (at home) and monitored to see if your antibiotic is working well.

Melun
NCT06910878Recruiting
Studying resistant bacteria in urine infections

This study looks at urine infections caused by certain resistant bacteria. If you had a UTI treated by your family doctor between June and December 2024, your doctor may help us learn more about these infections and how to treat them better.

Strasbourg
NCT06409819Recruiting· Phase 1/Phase 2
Phage therapy for recurrent UTIs in kidney transplant patients

This trial tests a phage (virus that kills bacteria) treatment for women who have had a kidney transplant and keep getting urinary tract infections (UTIs) caused by E. coli bacteria. It aims to see if this therapy can help prevent future infections.

La Jolla, California
NCT07461337Not yet recruiting· Phase 1/Phase 2
Phage therapy for a resistant joint infection

This trial tests a virus-based treatment (bacteriophage) for a chronic joint infection caused by a specific bacteria that hasn't responded to other treatments.

Calgary
NCT07619924Enrolling by invitation· Early Phase 1
Phage Cocktail for Hard-to-Treat Skin Infections

This study tests a new treatment called a phage cocktail (viruses that kill bacteria) for skin infections caused by bacteria that don't respond well to regular antibiotics. The treatment is applied directly to the wound to see if it's safe and effective.

Xi'an, Shaanxi
NCT06559618Recruiting· Phase 1
Phage therapy for bladder bacteria in spinal cord injury

This trial tests whether a special virus (bacteriophage) that attacks E. coli bacteria can help control bacteria in the bladder without causing an infection. It's for people with spinal cord injury who use a catheter and have E. coli in their urine but no active infection.

St Louis, Missouri

Hear when a new Urinary Tract Infections trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.